Open Access

[Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN

  • Authors:
    • Kai Liu
    • Songyang Liu
    • Wei Zhang
    • Baoxing Jia
    • Ludong Tan
    • Zhe Jin
    • Yahui Liu
  • View Affiliations

  • Published online on: November 30, 2021     https://doi.org/10.3892/or.2021.8236
  • Article Number: 25
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

February-2022
Volume 47 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z and Liu Y: [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN. Oncol Rep 47: 25, 2022
APA
Liu, K., Liu, S., Zhang, W., Jia, B., Tan, L., Jin, Z., & Liu, Y. (2022). [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN. Oncology Reports, 47, 25. https://doi.org/10.3892/or.2021.8236
MLA
Liu, K., Liu, S., Zhang, W., Jia, B., Tan, L., Jin, Z., Liu, Y."[Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN". Oncology Reports 47.2 (2022): 25.
Chicago
Liu, K., Liu, S., Zhang, W., Jia, B., Tan, L., Jin, Z., Liu, Y."[Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN". Oncology Reports 47, no. 2 (2022): 25. https://doi.org/10.3892/or.2021.8236